Year: 2021

Trondheim, 21 December 2021: NORBIT today announces that NORBIT ITS has received an order from an existing undisclosed European customer for delivery of enforcement modules to satellite-based tolling systems. The order has a value of more than NOK 35 million and is scheduled for delivery over the next 15 months from NORBIT’s fully automated production line at Røros. Enforcement modules are one of several products based on the company’s dedicated short-range communication (DSRC) technology which is delivered from ITS, a subsegment of NORBIT Connectivity. “We are delighted to receive an additional order from a long-term customer. This proves the attractiveness of NORBIT´s tailored enforcement modules customized for integration into satellite-based tolling On-Board Units,” says Per Jørgen Weisethaunet, CEO of NORBIT. For further queries,...

SAMPO PLC                 STOCK EXCHANGE RELEASE         21/12/2021 at 08:30 am Sampo plc’s share buybacks 20/12/2021 On 20/12/2021 Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI0009003305) as follows:                Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  22,596 42.71 AQEU  15,247 42.72 CEUX  4,184 42.67 TQEX  87,913 42.72 XHELTOTAL 129,940 42.72  *rounded to two decimals                 On 1 October 2021, Sampo announced a share buyback programme of up to a maximum of EUR 750 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 4 October 2021,...

BRISBANE, Australia, Dec. 21, 2021 (GLOBE NEWSWIRE) — Allkem Limited (ASX |TSX: AKE) (“Allkem” or the “Company”) advises the release of the Feasibility Study and Maiden Ore Reserve for its wholly owned James Bay Lithium Project (“James Bay” or the “Project”) located in Québec, Canada. HIGHLIGHTSFeasibility Study confirms a sustainable, high value hard rock lithium operation utilising renewable hydropower Material ~2.5x increase in Net Present Value (“NPV”) from the Preliminary Economic Assessment (“PEA”) released in March 2021 Construction planned to commence in Q3 CY2022 with commissioning in the first quarter of CY24, subject to receipt of necessary environmental and other approvals Strategically located in proximity to high-growth electric vehicle markets in North America and EuropeProject DetailsMineral Resource of 40.3Mt...

Casino Group and GreenYellow announce strategic collaborationon energy and cloud with Amazon Web Services Paris, 21 December 2021 GreenYellow, subsidiary of Casino Group and an expert in decentralized solar photovoltaic production, will supply renewable electricity for Amazon’s operations. Amazon Web Services (AWS) will support Casino Group on its digital transformation. Casino Group and Amazon Web Services agreed to a strategic collaboration to aid each company’s sustainability goals. Casino Group, through its energy subsidiary GreenYellow, which is a major international player in decentralized solar power generation and energy efficiency, is pleased to announce it agreed to a Corporate Power Purchase Agreement (PPA) with Amazon for a new utility-scale solar project in France. The deal highlights GreenYellow’s ability to provide renewable...

Chinese National Medical Products Administration (NMPA) granted Drug Approval License for Cresemba in China to Basilea’s license partner PfizerAd hoc announcement pursuant to Art. 53 LR Basel, Switzerland, December 21, 2021 Basilea Pharmaceutica Ltd. (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with infectious diseases and cancer, announced today that its license partner, Pfizer Inc. (NYSE: PFE, “Pfizer”), has received a Drug Approval License from the National Medical Products Administration (NMPA) in China, for the oral formulation of its antifungal Cresemba® (isavuconazole). With this authorization, oral Cresemba is now approved in China for the treatment of adult patients with invasive mucormycosis. The granting of the Drug Approval License triggered a milestone payment of USD...

THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION.Publication in application of Article 15 of the Law of 2 May 2007 (the Transparency Law)Acacia Pharma Group plc As previously announced1, Acacia Pharma Group plc issued ordinary shares to its Employee Benefit Trust within the authorised capital. The gross amount of this capital increase amounted to GBP 22,909.44 via an issue of 1,145,472 new shares at an issue price of GBP 0.02 per share. The shares were issued to satisfy the vesting of share awards granted under the Company’s Performance Share Plan.Total amount of share capital on 21 December 2021 GBP 2,017,188.46Total amount of share premium on 21 December 2021 GBP 142,087,474.57Total number of shares with voting rights on 21 December 2021 100,859,423Total number of voting rights on 21 December 2021 (denominator) 100,859,423Total...

21 December 2021, 7:00am, Antwerp, Belgium: VGP NV (‘VGP’ or ‘the Group’), a European provider of high-quality logistics and semi-industrial real estate, will soon switch all its European office locations to renewable energy as an agreement was reached with Scholt Energy B.V., the independent energy supplier, and ACT Commodities B.V., the European energy trading house, to purchase 100% renewable electricity for all its European office locations. The Virtual Power Purchase Agreement (VPPA) will provide power supplied from VGP’s existing solar farm on the roofs of VGP Park Nijmegen, Netherlands, to VGP offices across Europe. The solar farm at VGP Park Nijmegen today has a combined power output of almost 4,400 megawatt hours in total of which 2,100 megawatt hour is currently being utilised by local tenants. Of the remaining output circa 450...

          Louvain-La-Neuve, Belgium, December 21, 2021 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a contract for the installation of a Proteus®ONE1 proton therapy solution with the New Mexico Cancer Center in Albuquerque, NM, USA. The contract includes a long-term operation maintenance agreement. The contract is for the delivery of a Proteus®ONE solution, equipped with Pencil Beam Scanning (PBS), Cone Beam Computed Tomography (CBCT), Hand Pendant with contextual menus for easy patient positioning and the patient focused healthcare environment Philips Ambient Experience. New Mexico Cancer Center expects to treat its first patients by 2024. The typical end-user price...